- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Michael Kolodziej Discusses the Role of Commercial Payers in Value-Based Care
Michael Kolodziej, MD, vice president and chief innovation officer at ADVI Health, Inc., weighs in on the role of commercial payers in value-based care.
Michael Kolodziej, MD, vice president and chief innovation officer at ADVI Health, Inc., weighs in on the role of commercial payers in value-based care.
Transcript
Are commercial payers beginning to have a bigger presence in value-based care?
The issue with commercial payers is that they’re very interesting in doing things that are easy for them administratively. I don’t think they’re going to embrace [Oncology Care Model]. It’s just too complicated. It’s just too much work. I believe pathways are going to be—and you can certainly define pathways as value-based care. In fact, there is no definition of value-based care. There’s a broad spectrum of what constitutes value-based care, and pathways clearly exists within that spectrum.
I think payers will all adopt some sort of “value-based care program.” It might not be what the folks at OncoCloud consider value-based care, but it is by the strictest sense of the word a model of care.
New Insights Into Meth-Associated PAH Care Gaps: Anjali Vaidya, MD, on Closing the Divide
June 4th 2025Research from Anjali Vaidya, MD, FACC, FASE, FACP, Temple University Hospital, reveals critical care gaps for patients with methamphetamine-associated pulmonary arterial hypertension (PAH), emphasizing the need for early diagnosis and integrated support.
Read More
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Tailored Dosing for MM Matters More Than Drug Count: Ajai Chari, MD
April 25th 2025When it comes to treating multiple myeloma (MM), Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't necessarily guarantee better outcomes.
Read More
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More
